These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding. Xiao G; Fan Q; Wang X; Zhou B Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14995-5000. PubMed ID: 23980182 [TBL] [Abstract][Full Text] [Related]
8. Pathological polyQ expansion does not alter the conformation of the Huntingtin-HAP40 complex. Huang B; Guo Q; Niedermeier ML; Cheng J; Engler T; Maurer M; Pautsch A; Baumeister W; Stengel F; Kochanek S; Fernández-Busnadiego R Structure; 2021 Aug; 29(8):804-809.e5. PubMed ID: 33909994 [TBL] [Abstract][Full Text] [Related]
9. The Biology of Huntingtin. Saudou F; Humbert S Neuron; 2016 Mar; 89(5):910-26. PubMed ID: 26938440 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Zala D; Colin E; Rangone H; Liot G; Humbert S; Saudou F Hum Mol Genet; 2008 Dec; 17(24):3837-46. PubMed ID: 18772195 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration. Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462 [TBL] [Abstract][Full Text] [Related]
12. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion. Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195 [TBL] [Abstract][Full Text] [Related]
14. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease. Bithell A; Johnson R; Buckley NJ Biochem Soc Trans; 2009 Dec; 37(Pt 6):1270-5. PubMed ID: 19909260 [TBL] [Abstract][Full Text] [Related]
15. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. Ehrnhoefer DE; Duennwald M; Markovic P; Wacker JL; Engemann S; Roark M; Legleiter J; Marsh JL; Thompson LM; Lindquist S; Muchowski PJ; Wanker EE Hum Mol Genet; 2006 Sep; 15(18):2743-51. PubMed ID: 16893904 [TBL] [Abstract][Full Text] [Related]
16. SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. Sittler A; Wälter S; Wedemeyer N; Hasenbank R; Scherzinger E; Eickhoff H; Bates GP; Lehrach H; Wanker EE Mol Cell; 1998 Oct; 2(4):427-36. PubMed ID: 9809064 [TBL] [Abstract][Full Text] [Related]
17. The emerging role of the first 17 amino acids of huntingtin in Huntington's disease. Arndt JR; Chaibva M; Legleiter J Biomol Concepts; 2015 Mar; 6(1):33-46. PubMed ID: 25741791 [TBL] [Abstract][Full Text] [Related]
18. Putting huntingtin "aggregation" in view with windows into the cellular milieu. Hatters DM Curr Top Med Chem; 2012; 12(22):2611-22. PubMed ID: 23339311 [TBL] [Abstract][Full Text] [Related]
19. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein. Omi K; Hachiya NS; Tanaka M; Tokunaga K; Kaneko K Neurosci Lett; 2008 Jan; 431(1):45-50. PubMed ID: 18078716 [TBL] [Abstract][Full Text] [Related]
20. Interaction with polyglutamine-expanded huntingtin alters cellular distribution and RNA processing of huntingtin yeast two-hybrid protein A (HYPA). Jiang YJ; Che MX; Yuan JQ; Xie YY; Yan XZ; Hu HY J Biol Chem; 2011 Jul; 286(28):25236-45. PubMed ID: 21566141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]